About 2 results found for searched term "Siplizumab" (0.131 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25205 | Siplizumab | Others |
| MEDI-507 | ||
| Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells. | ||
| M25085 | Geptanolimab | PD-1/PD-L1 |
| APL-501; CBT-501; GB-226 | ||
| Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
